{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:31:55Z","timestamp":1789662715686,"version":"4.0.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bestpracticeobgyn.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.bpobgyn.2014.11.001","type":"journal-article","created":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T05:03:38Z","timestamp":1415768618000},"page":"479-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Polycystic ovaries and obesity"],"prefix":"10.1016","volume":"29","author":[{"given":"Ioannis E.","family":"Messinis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina I.","family":"Messini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8655-540X","authenticated-orcid":false,"given":"George","family":"Anifandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Dafopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2014.11.001_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/1043-2760(89)90003-9","article-title":"Polycystic ovary syndrome","volume":"1","author":"Franks","year":"1989","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-2007-967093","article-title":"Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome","volume":"115","author":"Hahn","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib5","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1210\/jc.2006-2725","article-title":"Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance","volume":"92","author":"Carmina","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/REP-09-0568","article-title":"The adverse effects of obesity on conception and implantation","volume":"140","author":"Brewer","year":"2010","journal-title":"Reproduction"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib7","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1210\/endo.143.8.8961","article-title":"Dihydrotestosterone inhibits granulosa cell proliferation by decreasing the cyclin D2 mRNA expression and cell cycle arrest at G1 phase","volume":"143","author":"Pradeep","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib8","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/humrep\/16.10.2061","article-title":"Effects of androstenedione, insulin and luteinizing hormone on steroidogenesis in human granulosa luteal cells","volume":"16","author":"Greisen","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib9","first-page":"2414","article-title":"5alpha-reductase activity in women with polycystic ovary syndrome","volume":"84","author":"Jakimiuk","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-789X.2012.01053.x","article-title":"The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis","volume":"14","author":"Lim","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib11","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.fertnstert.2009.04.033","article-title":"Ovarian control of pituitary sensitivity of luteinizing hormone secretion to gonadotropin-releasing hormone in women with the polycystic ovary syndrome","volume":"92","author":"Dafopoulos","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib12","first-page":"4047","article-title":"Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"85","author":"Eagleson","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib13","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2005-2099","article-title":"Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions","volume":"91","author":"Pag\u00e1n","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib14","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1210\/jc.2007-2656","article-title":"Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women","volume":"93","author":"Lawson","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib15","first-page":"1692","article-title":"Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance\/hyperinsulinemia","volume":"82","author":"Laughlin","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/oxfordjournals.humrep.a138480","article-title":"Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis","volume":"9","author":"Hillier","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib17","first-page":"3984","article-title":"Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation","volume":"83","author":"Willis","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/edrv.20.4.0374","article-title":"The insulin-related ovarian regulatory system in health and disease","volume":"20","author":"Poretsky","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome","volume":"26","author":"Gambineri","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/humupd\/dmq027","article-title":"Insulin-like growth factor binding protein-1 in PCOS: a systematic review and meta-analysis","volume":"17","author":"Kelly","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib21","first-page":"801","article-title":"Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions","volume":"18","author":"Rajaram","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib22","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/oxfordjournals.humrep.a135772","article-title":"Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women","volume":"10","author":"Clark","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/humupd\/5.1.52","article-title":"Leptin in human reproduction","volume":"5","author":"Messinis","year":"1999","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mce.2012.10.010","article-title":"Adipocyte biology in polycystic ovary syndrome","volume":"373","author":"Barber","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"4 Suppl.","key":"10.1016\/j.bpobgyn.2014.11.001_bib25","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.fertnstert.2008.03.007","article-title":"Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome","volume":"91","author":"Carmina","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.fertnstert.2012.03.056","article-title":"Adipose expression of adipocytokines in women with polycystic ovary syndrome","volume":"98","author":"Svendsen","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/humupd\/dmp006","article-title":"Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis","volume":"15","author":"Toulis","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib28","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1007\/s13277-013-1595-0","article-title":"Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis","volume":"35","author":"Li","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib29","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.fertnstert.2004.11.077","article-title":"Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome","volume":"83","author":"Ardawi","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1365-2265.2009.03604.x","article-title":"Adiponectin levels in adolescent girls with polycystic ovary syndrome","volume":"71","author":"Pinhas-Hamiel","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mce.2008.01.007","article-title":"Role of adiponectin in regulating ovarian theca and granulosa cell function","volume":"284","author":"Lagaly","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.tem.2007.07.003","article-title":"Abdominal adiposity and the polycystic ovary syndrome","volume":"18","author":"Escobar-Morreale","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib34","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3109\/09513590.2011.569794","article-title":"The plasma level and gene expression of resistin in polycystic ovary syndrome","volume":"27","author":"Zhang","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humrep\/deh010","article-title":"Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance","volume":"19","author":"Seow","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/2042018811423770","article-title":"Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome","volume":"2","author":"Pangaribuan","year":"2011","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib38","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/dmrr.1201","article-title":"Visfatin in overweight\/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review","volume":"27","author":"Chang","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib39","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/humrep\/dem118","article-title":"Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome","volume":"22","author":"Kowalska","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib40","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1530\/EJE-07-0294","article-title":"Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance","volume":"157","author":"Tan","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib42","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/humrep\/dei128","article-title":"Ovulation induction: a mini review","volume":"20","author":"Messinis","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib43","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.fertnstert.2011.09.006","article-title":"Randomized comparison of the influence of dietary management and\/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome","volume":"96","author":"Nybacka","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib44","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.fertnstert.2013.06.030","article-title":"Serum antim\u00fcllerian hormone in response to dietary management and\/or physical exercise in overweight\/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial","volume":"100","author":"Nybacka","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib45","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3109\/09513590.2012.736563","article-title":"Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome","volume":"29","author":"Nascimento","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib46","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/09513590.2012.736557","article-title":"Diet, physical exercise and Orlistat administration increase serum anti-M\u00fcllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)","volume":"29","author":"Vosnakis","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib47","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/humrep\/del473","article-title":"The preconceptual contraception paradigm: obesity and infertility","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib48","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/humrep\/dem426","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"23","author":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib49","first-page":"196","article-title":"Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation","volume":"62","author":"Hammond","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib50","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humupd\/3.4.359","article-title":"Modern use of clomiphene citrate in induction of ovulation","volume":"3","author":"Kousta","year":"1997","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib51","first-page":"676","article-title":"Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"85","author":"Imani","year":"2000","journal-title":"J\u00a0Clin Endocrino Metab"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib52","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.fertnstert.2008.03.011","article-title":"Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory infertile patients with polycystic ovary syndrome","volume":"91","author":"Palomba","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib53","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/humrep\/deq254","article-title":"Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial","volume":"25","author":"Palomba","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib54","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/humupd\/dmn033","article-title":"Use of letrozole in assisted reproduction: a systematic review and meta-analysis","volume":"14","author":"Requena","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib55","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.fertnstert.2011.08.002","article-title":"Body mass index-associated differences in response to ovulation induction with letrozole","volume":"96","author":"McKnight","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib56","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/humrep\/deg336","article-title":"A\u00a0comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome","volume":"18","author":"Christin-Maitre","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib57","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/humupd\/5.5.493","article-title":"Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements","volume":"5","author":"Homburg","year":"1999","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib58","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/humupd\/3.3.235","article-title":"Current and future status of ovulation induction in polycystic ovary syndrome","volume":"3","author":"Messinis","year":"1997","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib59","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1093\/humrep\/deg459","article-title":"High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2)","volume":"18","author":"Eijkemans","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib60","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1471-0528.1992.tb14470.x","article-title":"Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin","volume":"99","author":"Hamilton-Fairley","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib61","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/bmj.332.7539.434","article-title":"Should obese women with polycystic ovary syndrome receive treatment for infertility?","volume":"332","author":"Balen","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0015-0282(01)02928-4","article-title":"Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency","volume":"77","author":"Imani","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib63","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.fertnstert.2006.05.046","article-title":"Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome","volume":"86","author":"van Wely","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib64","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1530\/eje.0.1470223","article-title":"FSH response-dose can be predicted in ovulation induction for normogonadotropic anovulatory infertility","volume":"147","author":"van Santbrink","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib65","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/humrep\/deh343","article-title":"Ovulation induction using laparoscopic ovarian drilling in women with polycystic ovarian syndrome: predictors of success","volume":"19","author":"Amer","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib66","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/bmj.38867.631551.55","article-title":"Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial","volume":"332","author":"Moll","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib67","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib68","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/humupd\/dmm026","article-title":"The role of metformin in polycystic ovary syndrome: a systematic review","volume":"13","author":"Moll","year":"2007","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib69","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1210\/jcem.85.8.6738","article-title":"Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome","volume":"85","author":"Pasquali","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib70","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2004.02.104","article-title":"A\u00a0randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and\/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study","volume":"82","author":"Hoeger","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib71","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1093\/humrep\/dem271","article-title":"Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial","volume":"22","author":"Trolle","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib72","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1479-828X.2011.01295.x","article-title":"Analysis of factors predicting success of metformin and clomiphene treatment for women with infertility owing to PCOS-related ovulation dysfunction in a randomised controlled trial","volume":"51","author":"Johnson","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib73","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/humupd\/dms036","article-title":"Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"19","author":"Misso","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/humupd\/dmi036","article-title":"A\u00a0meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome","volume":"12","author":"Heijnen","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib75","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.fertnstert.2010.10.026","article-title":"Polycystic ovary syndrome and maternal obesity affect oocyte size in in\u00a0vitro fertilization\/intracytoplasmic sperm injection cycles","volume":"95","author":"Marquard","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib76","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/humrep\/del025","article-title":"The use of metformin for women with PCOS undergoing IVF treatment","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib77","first-page":"CD006105","article-title":"Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome","volume":"15","author":"Tso","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib78","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ejcn.2011.81","article-title":"Habitual dietary intake, eating pattern and physical activity of women with polycystic ovary syndrome","volume":"65","author":"Barr","year":"2011","journal-title":"Eur J Clin Nutr"},{"issue":"7","key":"10.1016\/j.bpobgyn.2014.11.001_bib79","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","author":"Moran","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib80","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.fertnstert.2008.12.003","article-title":"Heart rate recovery improves after weight loss in overweight and obese women with polycystic ovary syndrome","volume":"93","author":"Thomson","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib81","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1467-789X.2010.00758.x","article-title":"Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature","volume":"12","author":"Thomson","year":"2011","journal-title":"Obes Rev"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib82","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/08964289.2012.685498","article-title":"Health-related behaviors in women with lifestyle-related diseases","volume":"38","author":"Kozica","year":"2012","journal-title":"Behav Med"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib83","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1210\/jc.2008-0751","article-title":"The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome","volume":"93","author":"Thomson","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib84","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/humrep\/des138","article-title":"The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome","volume":"27","author":"Thomson","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/humupd\/dmn043","article-title":"Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis","volume":"15","author":"Nieuwenhuis-Ruifrok","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib86","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib87","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","author":"Elkind-Hirsch","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib88","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.fertnstert.2007.05.002","article-title":"Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"89","author":"Lindholm","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib89","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.fertnstert.2007.04.043","article-title":"Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels","volume":"89","author":"Panidis","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib90","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/cen.12305","article-title":"The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome","volume":"80","author":"Panidis","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib91","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1210\/jc.2005-1490","article-title":"The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery","volume":"90","author":"Escobar-Morreale","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.11.001_bib92","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4239\/wjd.v3.i4.71","article-title":"Defining the role of bariatric surgery in polycystic ovarian syndrome patients","volume":"3","author":"Malik","year":"2012","journal-title":"World J Diabetes"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693414002429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693414002429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T04:14:01Z","timestamp":1566015241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693414002429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1521693414002429"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.11.001","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic ovaries and obesity","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}